2nd Quarter - Report

ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
—
Expenses
$730,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Prescription Drug User Fee Act - implementation and general legislative planning

LobbyistCovered position, as disclosed
CHRISTINE BLOOMQUIST —
BRANTLEY CARLSON —
MARIA FIRVIDA —
THERESA JOLIVETTE —
NATALIE MORRIS —
JOHN MYERS —
LAURA OKPALA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Medicare Part D Coverage and Reimbursement Medicare Part D Non-Interference Legislative proposals to change Medicare Part D Medicare Part B coverage and remimbursement Medicaid Coverage

LobbyistCovered position, as disclosed
CHRISTINE BLOOMQUIST —
BRANTLEY CARLSON —
MARIA FIRVIDA —
JULIE GARNER —
THERESA JOLIVETTE —
NATALIE MORRIS —
JOHN MYERS —
LAURA OKPALA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) STRIKE Act - Senate Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 3211)

LobbyistCovered position, as disclosed
CHRISTINE BLOOMQUIST —
BRANTLEY CARLSON —
MARIA FIRVIDA —
JULIE GARNER —
THERESA JOLIVETTE —
NATALIE MORRIS —
JOHN MYERS —
LAURA OKPALA —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1628 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.